MX2016003347A - Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes. - Google Patents
Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes.Info
- Publication number
- MX2016003347A MX2016003347A MX2016003347A MX2016003347A MX2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A MX 2016003347 A MX2016003347 A MX 2016003347A
- Authority
- MX
- Mexico
- Prior art keywords
- dimethylpropan
- carboxy
- ethyl
- pharmaceutically acceptable
- aminium
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000037058 blood plasma level Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con el uso de 3-Carboxi-N-etil-N,N-dimetilpropan-1-aminio y su sal farmacéuticamente aceptable para disminuir los niveles de plasma en sangre de insulina y glucosa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13186201 | 2013-09-26 | ||
| PCT/IB2014/064514 WO2015044828A1 (en) | 2013-09-26 | 2014-09-15 | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016003347A true MX2016003347A (es) | 2016-06-24 |
| MX368505B MX368505B (es) | 2019-10-04 |
Family
ID=49231372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016003347A MX368505B (es) | 2013-09-26 | 2014-09-15 | Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes. |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN105530929B (es) |
| AR (1) | AR099638A1 (es) |
| BR (1) | BR112016004211B1 (es) |
| CA (1) | CA2924682C (es) |
| JO (1) | JO3333B1 (es) |
| MX (1) | MX368505B (es) |
| TN (1) | TN2016000064A1 (es) |
| WO (1) | WO2015044828A1 (es) |
| ZA (1) | ZA201600894B (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2067474A1 (en) * | 2007-12-05 | 2009-06-10 | Grindeks, a joint stock company | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate |
| LV14345B (lv) | 2009-10-22 | 2011-07-20 | Grindeks, A/S | 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai |
| US20140088125A1 (en) * | 2011-04-27 | 2014-03-27 | Jsc Grindeks | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
-
2014
- 2014-08-05 JO JOP/2014/0244A patent/JO3333B1/ar active
- 2014-08-13 AR ARP140103039A patent/AR099638A1/es unknown
- 2014-09-15 CA CA2924682A patent/CA2924682C/en active Active
- 2014-09-15 CN CN201480050485.3A patent/CN105530929B/zh active Active
- 2014-09-15 TN TN2016000064A patent/TN2016000064A1/en unknown
- 2014-09-15 MX MX2016003347A patent/MX368505B/es active IP Right Grant
- 2014-09-15 BR BR112016004211-5A patent/BR112016004211B1/pt active IP Right Grant
- 2014-09-15 WO PCT/IB2014/064514 patent/WO2015044828A1/en not_active Ceased
-
2016
- 2016-02-09 ZA ZA2016/00894A patent/ZA201600894B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX368505B (es) | 2019-10-04 |
| BR112016004211A2 (es) | 2017-08-01 |
| CN105530929A (zh) | 2016-04-27 |
| CA2924682A1 (en) | 2015-04-02 |
| AR099638A1 (es) | 2016-08-10 |
| TN2016000064A1 (en) | 2017-07-05 |
| CN105530929B (zh) | 2018-03-02 |
| BR112016004211B1 (pt) | 2022-09-06 |
| JO3333B1 (ar) | 2019-03-13 |
| WO2015044828A1 (en) | 2015-04-02 |
| CA2924682C (en) | 2018-02-27 |
| ZA201600894B (en) | 2017-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015500115B1 (en) | Glucagon analogues | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| PH12015501088A1 (en) | Dimeric compounds | |
| WO2014152754A3 (en) | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens | |
| MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
| EP3013219A4 (en) | Low glucose treatment for people with diabetes | |
| SA517381678B1 (ar) | مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي | |
| MX2017001737A (es) | Vitamina b2 y sus usos. | |
| MX2013009456A (es) | Compuestos de azufre aromaticos sustituidos y metodos para su uso. | |
| MX2016003347A (es) | Uso de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio o una sal farmaceuticamente aceptable del mismo en la prevencion y tratamiento de diabetes. | |
| MX351765B (es) | Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares. | |
| SI2699545T1 (sl) | Novi amino-pirolinski derivati in uporaba le-teh pri preprečevanju in/ali zdravljenju metaboličnega sindroma | |
| NZ631362A (en) | Arry-520 for use in treating cancer in a patient with low aag | |
| SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
| PH12015500178A1 (en) | Injectable supersaturated acetaminophen solution for spinal administration | |
| UA55885U (ru) | Способ коррекции повышенной агрегации тромбоцитов у больных гипертонической болезнью низкого и умеренного дополнительного риска | |
| PL2852400T3 (pl) | Analog insuliny lub jego farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna o przedłużonym działaniu terapeutycznym, zastosowanie analogu insuliny, sposób dawkowania oraz sposób leczenia cukrzycy | |
| UA97741C2 (ru) | Способ восстановления кожных покровов при глубоких распространенных ожогах микроаутодермотрансплантатами | |
| UA74052U (ru) | Способ профилактики боковых грыж живота у больных с функционирующей колостомой и вентральной грыжей | |
| UA97054C2 (ru) | Способ комплексного лечения больных с зависимостью вследствие употребления психоактивных веществ | |
| UA79303U (ru) | Применение таурина как средства стабилизации концентрации итраконазола в плазме крови при лечении грибковых заболеваний | |
| UA74055U (ru) | Способ хирургического лечения рефрактерных форм глаукомы | |
| AU2014903587A0 (en) | Regulation of a blood glucose level in a patient with diabetes | |
| HK1220133A1 (zh) | 改善微血管完整性的方法 | |
| UA56353U (ru) | Способ возобновления проходности слезоносового канала у детей с введением лекарственного средства |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |